Mice carrying a CMT-related MORC2 S87L heterozygous variant exhibited axonal neuropathy and skeletal muscle weakness, displaying the clinical symptoms expected in human CMT2Z patients19. This evidence concerns the gene MORC2 and Charcot-Marie-Tooth disease.